Corden Pharma

Plankstadt, DE · Caponago, IT · Boulder, CO
Program data pending ClinicalTrials.gov matching · Last scored 2026-03-15
65.5
Signal Score
✓ FDA Inspections (1) ○ Clinical Trials ○ SEC Filings ○ Press

Quick Facts: Corden Pharma

Signal Score
65.5/100 (as of 2026-03-15)
Quality Compliance
Assessment pending
Headquarters
Plankstadt, DE · Caponago, IT · Boulder, CO
Modalities
mRNA, Oligonucleotide, Biologics
Active CGT Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CGT manufacturing intelligence platform

Signal Score & Pillar Breakdown

Quality Compliance
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA Inspections1 on record
Warning Letters0
Last InspectionNo Action Indicated (NAI) (2025-11-14)
Operations
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs no verified data
Sponsorsno verified data
ModalitiesmRNA, Oligonucleotide, Biologics
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 68.0
Parent company: ICIG
Financial assessment: 68.0/100
Source: SEC EDGAR, press monitoring
Subsidiary of ICIG
SEC FilingsParent: ICIG
Parent company: ICIG
Financial assessment: 68.0/100
Capacity 63.0
3 CGT manufacturing sites
Sites: Plankstadt, Germany, Caponago, Italy, Boulder, CO
Source: SEC EDGAR, press monitoring, company profiles
3 CGT manufacturing sites
3 CGT manufacturing sites

FDA Inspection History

2025-11
NAI VAI OAI
Date Site Type Observations Classification
2025-11-14 Boulder, Colorado Drug Quality Assurance No No Action Indicated (NAI)
Source: FDA Data Dashboard · Retrieved Mar 20, 2026
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
mRNA CDMOs → Oligonucleotide CDMOs → Biologics CDMOs →